PortfoliosLab logo

Avadel Pharmaceuticals plc (AVDL)

Equity · Currency in USD · Last updated Jun 28, 2022

Company Info

ISINUS05337M1045
CUSIP05337M104
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic

Trading Data

Previous Close$2.43
Year Range$1.07 - $11.18
EMA (50)$3.60
EMA (200)$6.11
Average Volume$4.85M
Market Capitalization$143.46M

AVDLShare Price Chart


Chart placeholderClick Calculate to get results

AVDLPerformance

The chart shows the growth of $10,000 invested in Avadel Pharmaceuticals plc on Jan 5, 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $3,227 for a total return of roughly -67.73%. All prices are adjusted for splits and dividends.


AVDL (Avadel Pharmaceuticals plc)
Benchmark (^GSPC)

AVDLReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-2.80%-6.21%
YTD-69.93%-18.17%
6M-69.08%-17.47%
1Y-66.48%-8.89%
5Y-25.42%10.04%
10Y-5.84%11.39%

AVDLMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

AVDLSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Avadel Pharmaceuticals plc Sharpe ratio is -0.39. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


AVDL (Avadel Pharmaceuticals plc)
Benchmark (^GSPC)

AVDLDividend History


Avadel Pharmaceuticals plc doesn't pay dividends

AVDLDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


AVDL (Avadel Pharmaceuticals plc)
Benchmark (^GSPC)

AVDLWorst Drawdowns

The table below shows the maximum drawdowns of the Avadel Pharmaceuticals plc. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Avadel Pharmaceuticals plc is 95.83%, recorded on May 26, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-95.83%Jul 29, 20151721May 26, 2022
-68.85%Mar 30, 2010692Dec 26, 2012259Jan 7, 2014951
-39.12%Dec 22, 201416Jan 14, 201594Jun 1, 2015110
-32.38%Mar 21, 201418Apr 15, 201446Jun 20, 201464
-25.48%Aug 22, 201453Nov 5, 201419Dec 3, 201472
-16.36%Jan 15, 201418Feb 10, 201424Mar 17, 201442
-14.35%Jan 21, 201011Feb 4, 201036Mar 29, 201047
-12.92%Jun 23, 201411Jul 8, 201432Aug 21, 201443
-8.33%Jun 23, 201511Jul 8, 20154Jul 14, 201515
-6.54%Jul 24, 20151Jul 24, 20152Jul 28, 20153

AVDLVolatility Chart

Current Avadel Pharmaceuticals plc volatility is 64.94%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


AVDL (Avadel Pharmaceuticals plc)
Benchmark (^GSPC)

Portfolios with Avadel Pharmaceuticals plc


Loading data...